First global patient recruited for rare blood cancer study at King’s
The UK’s King's College Hospital NHS Foundation Trust has announced the first global patient recruitment for TAK-226-3001, a Takeda Pharmaceuticals’…
News
Novartis’ $12bn Avidity bet falters on late-stage del-desiran flop
Novo’s Wegovy touts obesity-treating potential in patients as young as six
Rezubio doses first cohort in Phase I trial of inhaled RZ-520
Novo Nordisk’s ziltivekimab stumbles again on pair of Phase III terminations
Clover’s respiratory combo vaccines secure Phase II wins in elderly recipients
Acepodia secures FDA clearance to begin Phase I ACE723 trial
Novartis’ pelacarsen fails to meet primary endpoint in Lp(a)HORIZON trial
